Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 11

1.

USA's expanded overseas tuberculosis screening program: a retrospective study in China.

Liang S, Zhang J, Hu L, Chen J, Wu J, Huang Y, Zeng Y, Zhu Y, Li Z, Wen Y, Liang W, Zhuo J, He H.

BMC Public Health. 2015 Mar 7;15:231. doi: 10.1186/s12889-015-1558-z.

2.

Revisiting rates of reactivation tuberculosis: a population-based approach.

Horsburgh CR Jr, O'Donnell M, Chamblee S, Moreland JL, Johnson J, Marsh BJ, Narita M, Johnson LS, von Reyn CF.

Am J Respir Crit Care Med. 2010 Aug 1;182(3):420-5. doi: 10.1164/rccm.200909-1355OC. Epub 2010 Apr 15.

3.

Housing insecurity and lack of public assistance are risk factors for tuberculin skin test conversion among persons who use illicit drugs in New York City.

Sivapalasingam S, Klein RS, Howard A, Qin A, Tseng CH, Gourevitch MN.

J Addict Med. 2009 Sep;3(3):172-7. doi: 10.1097/ADM.0b013e31819eac4c.

4.

Polymorphic exact tandem repeat A (PETRA): a newly defined lineage of mycobacterium tuberculosis in israel originating predominantly in Sub-Saharan Africa.

Freidlin PJ, Goldblatt D, Kaidar-Shwartz H, Rorman E.

J Clin Microbiol. 2009 Dec;47(12):4006-20. doi: 10.1128/JCM.01270-09. Epub 2009 Oct 21.

5.

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics.

MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166.

6.

Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.

Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR.

Am J Respir Crit Care Med. 2009 Aug 15;180(4):365-70. doi: 10.1164/rccm.200901-0146OC. Epub 2009 May 29.

7.

The challenge of multisite epidemiologic studies in diverse populations: design and implementation of a 22-site study of tuberculosis in foreign-born people.

Davidow AL, Katz D, Reves R, Bethel J, Ngong L; Tuberculosis Epidemiologic Studies Consortium.

Public Health Rep. 2009 May-Jun;124(3):391-9.

8.

Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study.

Page KR, Manabe YC, Adelakun A, Federline L, Cronin W, Campbell JD, Dorman SE.

BMC Public Health. 2008 May 12;8:158. doi: 10.1186/1471-2458-8-158.

9.

Reproducibility of QuantiFERON-TB gold in-tube assay.

Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J.

Clin Vaccine Immunol. 2008 Mar;15(3):425-32. doi: 10.1128/CVI.00398-07. Epub 2008 Jan 16.

10.

Bilateral neck swelling in a 40-year-old woman with HIV.

Chau B, Gupta M, Schucany WG.

Proc (Bayl Univ Med Cent). 2007 Oct;20(4):392-7. No abstract available.

11.

Mortality associated with central nervous system tuberculosis.

El Sahly HM, Teeter LD, Pan X, Musser JM, Graviss EA.

J Infect. 2007 Dec;55(6):502-9. Epub 2007 Oct 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk